MannKind | MNKD - Ativo Circulante





Ativo Circulante Alterar Data
Adma Biologics USD 528.2M 17.03M 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Insmed USD 1.63B 20.75M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Merck USD 36.68B 1.66B 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Novavax USD 771.1M 79.72M 2026-06
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Xencor USD 523.21M 40.36M 2026-06